Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: May 28, 2003
Last updated: January 24, 2007
Last verified: January 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2006
  Estimated Primary Completion Date: No date given